Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 1, [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the [***].
Appears in 3 contracts
Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.), Collaboration and License Agreement (Kymera Therapeutics, Inc.), Collaboration and License Agreement (Kymera Therapeutics, Inc.)
Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 1[***], [***] will have the first right (but not the obligation) to Prosecute and Maintain the all [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the such [***].
Appears in 2 contracts
Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.), Collaboration and License Agreement (Kymera Therapeutics, Inc.)
Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 1[***], [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the such [***].
Appears in 2 contracts
Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.), Collaboration and License Agreement (Kymera Therapeutics, Inc.)
Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 12, [***] will have the first right (but not the obligation) to Prosecute and Maintain the all [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the such [***].
Appears in 1 contract
Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.)
Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 1[***], [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the [***].
Appears in 1 contract
Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.)
Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 1[***], [***] will have the first right (but not the 110 CONFIDENTIAL obligation) to Prosecute and Maintain the [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the such [***].
Appears in 1 contract
Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.)
Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 1[***], [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the [***].. 109 12.2.5 [***]. Subject to Section 12.2.4, the Parties will divide responsibility for the Prosecution and Maintenance of [***], other than [***], as follows:
Appears in 1 contract
Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.)
Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 1[***], [***] will have the first right (but not the obligation) to Prosecute and Maintain the all [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the such [***].
Appears in 1 contract
Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.)
Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 1[***], [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the [***].
Appears in 1 contract
Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.)